PI Post Acute Access Act aims to enhance Medicare coverage for primary immunodeficiency patients by including intravenous immune globulin treatments.
The PI Post Acute Access Act seeks to amend title XVIII of the Social Security Act to improve access to skilled nursing facilities for primary immunodeficiency patients. Specifically, it adds a new subclause to Section 1888(e)(2)(A)(iii) of the Social Security Act, including intravenous immune globulin treatments for primary immune deficiency disease under Medicare coverage. This change will apply to items and services furnished on or after October 1, 2026.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.